{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:57Z","timestamp":1792294497601,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R21DA055427"],"award-info":[{"award-number":["1R21DA055427"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.msard.2025.106443","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:10:31Z","timestamp":1744643431000},"page":"106443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The unmet need for cannabis use disorder treatment in multiple sclerosis: Insights from a nationwide pilot study"],"prefix":"10.1016","volume":"98","author":[{"given":"Giuseppina","family":"Pilloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Pehel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Kreisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Sammarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Erik","family":"Charlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-9713","authenticated-orcid":false,"given":"Leigh","family":"Charvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2025.106443_bib0001","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/add.15743","article-title":"Clinical management of cannabis withdrawal","volume":"117","author":"Connor","year":"2022","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.msard.2025.106443_bib0002","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awz213","article-title":"Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis","volume":"142","author":"Feinstein","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2025.106443_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520934070","article-title":"Discontinuing cannabis improves depression in people with multiple sclerosis: a short report","volume":"27","author":"Feinstein","year":"2021","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106443_bib0004","doi-asserted-by":"crossref","first-page":"e2220","DOI":"10.1002\/brb3.2220","article-title":"Impaired awareness: why people with multiple sclerosis continue using cannabis despite evidence to the contrary","volume":"11","author":"Feinstein","year":"2021","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.msard.2025.106443_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1465-3362.2011.00313.x","article-title":"Barriers and facilitators to cannabis treatment","volume":"31","author":"Gates","year":"2012","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.msard.2025.106443_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102830","article-title":"Patterns of medical cannabis use among patients diagnosed with multiple sclerosis","volume":"50","author":"Guarnaccia","year":"2021","journal-title":"Mult. Scler Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106443_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.msard.2025.106443_bib0008","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"20","key":"10.1016\/j.msard.2025.106443_bib0009","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172887","article-title":"Cannabis use disorder: from neurobiology to treatment","volume":"134","author":"Le Foll","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2025.106443_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103622","article-title":"The effects of cannabis abstinence on cognition and resting state network activity in people with multiple sclerosis: a preliminary study","volume":"43","author":"Meza","year":"2024","journal-title":"Neuroimage Clin."},{"issue":"2","key":"10.1016\/j.msard.2025.106443_bib0011","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","article-title":"The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews","volume":"18","author":"Nielsen","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.msard.2025.106443_bib0012","article-title":"Cannabis and cognitive functioning in multiple sclerosis: the role of gender","volume":"3","author":"Patel","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"6","key":"10.1016\/j.msard.2025.106443_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7224\/1537-2073.2021-036","article-title":"A survey of cannabis use in a large US-based cohort of people with multiple sclerosis","volume":"23","author":"Salter","year":"2021","journal-title":"Int. J. MS Care"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:35:11Z","timestamp":1747258511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":13,"alternative-id":["S2211034825001853"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106443","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The unmet need for cannabis use disorder treatment in multiple sclerosis: Insights from a nationwide pilot study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106443"}}